APA aipamena

Cella, D., Escudier, B., Rini, B., Chen, C., Bhattacharyya, H., Tarazi, J., . . . Motzer, R. (2013). Patient-reported outcomes for axitinib vs sorafenib in metastatic renal cell carcinoma: Phase III (AXIS) trial. Nature Publishing Group.

Chicago Style aipamena

Cella, D., B. Escudier, B. Rini, C. Chen, H. Bhattacharyya, J. Tarazi, B. Rosbrook, S. Kim, and R. Motzer. Patient-reported Outcomes for Axitinib Vs Sorafenib in Metastatic Renal Cell Carcinoma: Phase III (AXIS) Trial. Nature Publishing Group, 2013.

MLA aipamena

Cella, D., et al. Patient-reported Outcomes for Axitinib Vs Sorafenib in Metastatic Renal Cell Carcinoma: Phase III (AXIS) Trial. Nature Publishing Group, 2013.